Mario P. Colombo

Researcher Next ID · RN-035097

Researcher · Biochemistry, Genetics and Molecular Biology

Milan, Italy

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Medicine

Immunotherapy and Immune Responses

Immune cells in cancer

Cancer Immunotherapy and Biomarkers

Cancer Research and Treatments

CAR-T cell therapy research

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Clinical Cancer Research · 2018 · https://doi.org/10.1158/1078-0432.ccr-18-1390
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Nature Communications · 2016 · https://doi.org/10.1038/ncomms12150
Classification of current anticancer immunotherapies
Oncotarget · 2014 · https://doi.org/10.18632/oncotarget.2998
Risk Stratification in Brugada Syndrome
Journal of the American College of Cardiology · 2011 · https://doi.org/10.1016/j.jacc.2011.08.064
CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction
Immunity · 2008 · https://doi.org/10.1016/j.immuni.2008.08.018
The Terminology Issue for Myeloid-Derived Suppressor Cells
Cancer Research · 2007 · https://doi.org/10.1158/0008-5472.can-06-3037
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Journal of Clinical Investigation · 2006 · https://doi.org/10.1172/jci28828
Interleukin-12 in anti-tumor immunity and immunotherapy
Cytokine & Growth Factor Reviews · 2002 · https://doi.org/10.1016/s1359-6101(01)00032-6

No projects listed.